Mobile Menu - OpenMobile Menu - Closed

Subcommittee on Healthcare, Benefits, and Administrative Rules Hearing: “Examining the Impact of Voluntary Restricted Distribution Systems in the Pharmaceutical Supply Chain”

Date: 
Wednesday, March 22, 2017 - 2:00pm
Location: 
2154 Rayburn HOB

Witnesses

Mr. Bruce Leicher    
Senior Vice President and General Counsel, Momenta Pharmaceuticals    
Testifying on behalf of the Association for Accessible Medicines (AAM)        

Dr. Gerard Anderson    
Director, Center for Hospital Finance and Management    
Professor, Johns Hopkins Bloomberg School of Public Health       

Mr. David Mitchell    
President and Founder    
Patients for Affordable Drugs

115th Congress